BioVinc Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioVinc's estimated annual revenue is currently $930k per year.(i)
  • BioVinc's estimated revenue per employee is $155,000

Employee Data

  • BioVinc has 6 Employees.(i)
  • BioVinc grew their employee count by 0% last year.

BioVinc's People

NameTitleEmail/Phone
1
Founding member, Chief Operating OfficerReveal Email/Phone
2
Advisory Board ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is BioVinc?

BioVinc, LLC is a privately owned R&D company located in Pasadena, California. BioVinc offers the new fluorescent molecular probes targeting bone, based on technology developed by Professor Charles E. McKenna at the University of Southern California. The probes are derived from nitrogen-containing bisphosphonates such as risedronate (RIS) and zoledronate (ZOL), including lower affinity analogues, conjugated with a wide choice of popular visible and near infrared fluorescent dyes to address different imaging needs. Custom “mix-and-match” bisphosphonate-dye pairings are also available on request. The BioVinc team includes world-leading scientists on bisphosphonate chemistry, microscopy and pharmacology related to bone and bone diseases, whose expertise is at the disposal of our customers. The probes have been used in diverse imaging studies including research on bone metabolism, cancer and dental conditions. By providing both off-the-shelf imaging probes and individually tailored probe design services, BioVinc can help with all aspects of your research needs.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M620%N/A
#2
$0.4M6-25%N/A
#3
$0.4M6-14%N/A
#4
$0.4M6-14%N/A
#5
$0.9M60%N/A